FDA Approves New AndroGel Formulation

Share this article:

The FDA has approved Abbott's AndroGel 1.62%, a testosterone gel that restores levels of the hormone in hypogonadal men with half the volume of gel at the starting dose than delivered in AndroGel 1%.

The newly approved formulation contains 40.5 mg of testosterone in two pump presses, compared with the 1% gel's 50 mg in four pump presses.

With different dosage and administration instructions, the two gels are not interchangeable.

Share this article:
You must be a registered member of RUN to post a comment.

More in Hypogonadism

FDA Panel: Limit Testosterone Drug Use

FDA Panel: Limit Testosterone Drug Use

Joint committee also calls for drug makers to run heart-risk tests on popular 'Low T' products.

Insufficient Data on Benefits, Risks of Testosterone Drugs

Insufficient Data on Benefits, Risks of Testosterone Drugs

Expert panel to decide whether prescribing information on testosterone drugs should be changed.

Common Chemicals Lower Testosterone

Common Chemicals Lower Testosterone

Chemicals found in many household products may reduce androgen levels in both sexes.